参苓白术颗粒治疗63例功能性消化不良的效果观察  

Therapeutic effect of shenlingbaizhu granule in treatment of functional dyspepsia

作　　者：俞晶[1] 刘朝晖[1] 蔡晓曼[1] 陈素钻[1] 郭光华[1] 

机构地区：[1]汕头大学医学院第一附属医院消化内科,广东汕头515041

出　　处：《中国校医》2016年第5期379-380,共2页Chinese Journal of School Doctor

摘　　要：目的观察参苓白术颗粒对功能性消化不良患者的治疗效果。方法收集"脾胃气虚证"功能性消化不良患者126例,随机分成2组,观察组63例给予参苓白术颗粒治疗,对照组63例给予莫沙必利治疗,治疗8周后观察2组患者的临床疗效。结果观察组临床治愈率为19.05%,对照组为4.71%,差异有统计学意义(P<0.05);观察组显效率为33.33%,对照组为20.63%,2组差异有统计学意义(P<0.05);观察组总有效率为87.30%,对照组为57.14%,2组比较差异有统计学意义(P<0.05)。结论参苓白术颗粒对"脾胃气虚证"功能性消化不良患者的疗效明显优于莫沙必利。Objective To explore the therapeutic effect of shenlingbaizhu granule（a Chinese herbal compound） in the treatment of functional dyspepsia. Methods A total of 126 patients with functional dyspepsia（ ＂Deficiency of spleen and stomach syndrome＂ according to the Chinese medicine theory） were divided into a trail group and a control group（63cases each group）, and the former received shenlingbaizhu granule and the latter received mosapride. Eight weeks after the treatment, the therapeutic effects were evaluated. Results In the trial group, the clinical cure rate was 19.05%, but it was 4.71% in the control group（P〈0. 05）; The significant improvement rates were 33.33% and 20.63% in the trial group and control group respectively, and there was a significant difference（P〈 0.05）. The total effective rates were 87.30% and57.14% in the trial group and control group respectively and there was a significant difference（P 〈0.05）. Conclusion The therapeutic effect of shenlingbaizhu granule is superior to mosapride in the treatment of functional dyspepsia is.

关 键 词：消化不良/药物疗法 中草药/治疗应用 莫沙必利 

分 类 号：R573[医药卫生—消化系统]